Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: Preliminary results in 37 patients with contra-indications to iodinated contrast agents

Radiology

Volumn 235, Issue 3, 2005, Pages 819-826

  Remy Jardin, Martine ^a   Dequiedt, Philippe ^a   Ertzbischoff, Olivier ^b   Tillie Leblond, Isabelle ^a   Bruzzi, John ^a   Duhamel, Alain ^c   Remy, Jacques ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Schering SA   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CORTICOSTEROID; GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; IODINATED CONTRAST MEDIUM; PENICILLIN DERIVATIVE;

ADULT; AGED; ANAPHYLACTIC SHOCK; ANGIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CREATININE CLEARANCE; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFORMED CONSENT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LARYNX EDEMA; LUNG CIRCULATION; LUNG EMBOLISM; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY ANGIOGRAPHY; NAUSEA; NEPHROTOXICITY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN ALLERGY; STATISTICAL SIGNIFICANCE; TECHNOLOGY; THORAX RADIOGRAPHY; THORAX TUMOR; VOMITING; WILCOXON SIGNED RANKS TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 18844390781     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2353040734     Document Type: Article

References (30)

1. Katayama H, Yamaguchi K, Kozuka T, Tashima T, Seez P, Matuura K. Adverse reactions to ionic and nonionic contrast media. Radiology 1990; 175:621-628.
2. Kinno Y, Odagiri K, Andoh K, Itoh Y, Tarao K. Gadopentate dimeglumine as an alternative contrast material for use in angiography. AJR Am J Roentgenol 1993; 160:1293-1294.
3. Vehmas T, Markolla T. Gd-DTPA as an alternative contrast agent in conventional and interventional radiology. Acta Radiol 1998; 39:223-226.
4. Hammer FD, Goffette PP, Malaise J, Mathurin P. Gadolinium dimeglumine: an alternative contrast agent for digital substraction angiography. Eur Radiol 1999; 9:128-136.
5. Albrecht T, Dawson P. Gadolinium-DTPA as x-ray contrast medium in clinical studies. Br J Radiol 2000; 73:878-882.
6. Spinosa DJ, Kaufmann JA, Hartwell GD. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 2002; 223:319-325.
7. Bloem JL, Wondergem J. Gd-DTPA as a contrast agent in CT. Radiology 1989; 171:578-579.
8. Zwicker C, Langer M, Langer R, Keske U. Comparison of iodinated and noniodinated contrast media in computed tomography. Invest Radiol 1991; 26(suppl 1):S162-S164.
9. Luboldt W, De-Santis M, von-Smekal A, Reiser M. Attenuation characteristics and application of gadolinium-DTPA in fast helical computed tomography. Invest Radiol 1997; 32:690-695.
10. Gierada DS, Bae KT. Gadolinium as a CT contrast agent: assessment in a porcine model. Radiology 1999; 210:829-834.
11. Gupta AK, Alberico RA, Litwin A, Knater P, Grossman ZD. Gadopentate dimeglumine is potentially an alternative contrast agent for three-dimensional computed tomography angiography with multidetector-row helical scanning. J Comput Assist Tomogr 2002; 26:869-874.
12. Quinn AD, O'Hare NJ, Wallis FJ, Wilson GF. Gd-DTPA: an alternative contrast medium for CT. J Comput Assist Tomogr 1994; 18:634-636.
13. Kawano T, Ishijima H, Nakajima T, Aoki J, Endo K. Gd-DTPA: a possible alternative contrast agent for use in CT during intraarterial administration. J Comput Assist Tomogr 1999; 23:939-940.
14. Pena CS, Kaufman JA, Geller SC, Waltman AC. Gadopentate dimeglumine: a possible alternative contrast agent for CT angiography of the aorta. J Comput Assist Tomogr 1999; 23:23-24.
15. Karcaaltincaba M, Foley WD. Gadolinium-enhanced multidetector CT angiography of the thoracoabdominal aorta. J Comput Assist Tomogr 2002; 26:875-878.
16. Coche EE, Hammer FD, Gofette PP. Demonstration of pulmonary embolism with dynamic gadolinium-enhanced spiral CT. Eur Radiol 2001; 11:2306-2309.
17. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single breath hold technique-comparison with pulmonary angiography. Radiology 1992; 185:381-387.
18. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999; 10:477-484.
19. Schmitz SA, Wagner S, Schuhmann-Giampieri G, Wolf KJ. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography. Invest Radiol 1995; 30:644-649.
20. Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentate dimeglumine MRI studies in the same patients. Comput Med Imaging Graph 1994; 18:391-399.
21. Filippi M, Rovaris M, Capra R, et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis: implications for phase II clinical trials. Brain 1998; 121:2011-2020.
22. Thomsen HS, Almen T, Morcos SK. Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 2002; 12:2600-2605.
23. Niendorf HP, Haustein J, Louton AT, et al. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA: results of a randomized, controlled clinical trial. Invest Radiol 1991; 26(suppl 1): S221-S223.
24. Haustein J, Niendorp HP, Krestin G, et al. Renal tolerance of Gd-DTPA dimeglumine in patients with chronic renal failure. Invest Radiol 1992; 27:153-156.
25. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996; 6:162-166.
26. Swan SK, Baker JF, Free R, et al. Pharmacokinetics, safety, and tolerability of gadoversetamide injection (Optimark) in subjects with central nervous system or liver pathology and varying degrees of renal function. J Magn Reson Imaging 1999; 9:317-321.
27. Katzberg R. New and old contrast agents: physiology and nephrotoxicity. Urol Radiol 1988; 10:6-11.
28. Solomon R. Contrast-medium induced renal failure. Kidney Int 1998; 53:230-242.
29. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports of the U.S. Food and Drug Administration [published correction appears in Radiology 1997; 204:876.]. Radiology 1997; 203:605-610.
30. Tublin ME, Murphy ME, Tessler FN. Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol 1998; 171:933-939.